To kill a tumor cell: the potential of proapoptotic receptor agonists

Por Ashkenazi, Avi, Herbst, Roy S.
Publicado em 2008

Lung Cancer in the Era of Precision Medicine

Por Politi, Katerina, Herbst, Roy S.
Publicado no Clin Cancer Res (2015)

A RAS Renaissance: Emerging Targeted Therapies for KRAS-Mutated Non–Small Cell Lung Cancer

Por Vasan, Neil, Boyer, Julie, Herbst, Roy S.
Publicado no Clin Cancer Res (2014)

Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research

Por Schalper, Kurt A., Kaftan, Edward, Herbst, Roy S.
Publicado no Clin Cancer Res (2016)

“COMPANION DIAGNOSTICS”: Has their time come and gone?

Por Hirsch, Fred R., Bunn, Paul A., Herbst, Roy S
Publicado em 2014

Reports from 2010 Clinical and Translational Cancer Research Think Tank Meeting: Design Strategies for Personalized Therapy Trials

Por Berry, Donald A., Herbst, Roy S., Rubin, Eric H.
Publicado no Clin Cancer Res (2012)

New Strategies in Personalized Medicine for Solid Tumors: Molecular Markers and Clinical Trial Designs

Por Jürgensmeier, Juliane M., Eder, Joseph P., Herbst, Roy S.
Publicado no Clin Cancer Res (2014)

GSK-3α Is a Novel Target of CREB and CREB-GSK-3α Signaling Participates in Cell Viability in Lung Cancer

Por Park, Sin-Aye, Lee, Jong Woo, Herbst, Roy S., Koo, Ja Seok
Publicado no PLoS One (2016)

Design of a phase III clinical trial with prospective biomarker validation: SWOG S0819

Por Redman, Mary W., Crowley, John J., Herbst, Roy S., Hirsch, Fred R., Gandara, David R.
Publicado em 2012

Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (dulanermin), a Dual Pro-apoptotic Receptor (DR4/DR5) Agonist

Por Subbiah, Vivek, Brown, Robert E, Buryanek, Jamie, Trent, Jonathan, Ashkenazi, Avi, Herbst, Roy, Kurzrock, Razelle
Publicado em 2012

E2F8 as a Novel Therapeutic Target for Lung Cancer

Por Park, Sin-Aye, Platt, James, Lee, Jong Woo, López-Giráldez, Francesc, Herbst, Roy S., Koo, Ja Seok
Publicado no J Natl Cancer Inst (2015)

Bayesian Two-stage Biomarker-based Adaptive Design for Targeted Therapy Development

Por Gu, Xuemin, Chen, Nan, Wei, Caimiao, Liu, Suyu, Papadimitrakopoulou, Vassiliki A., Herbst, Roy S., Lee, J. Jack
Publicado no Stat Biosci (2014)

Production of Experimental Malignant Pleural Effusions Is Dependent on Invasion of the Pleura and Expression of Vascular Endothelial Growth Factor/Vascular Permeability Factor by H...

Por Yano, Seiji, Shinohara, Hisashi, Herbst, Roy S., Kuniyasu, Hiroki, Bucana, Corazon D., Ellis, Lee M., Fidler, Isaiah J.
Publicado em 2000

Clinical significance of PD-L1 protein expression on tumor-associated macrophages in lung cancer

Por Schalper, Kurt Alex, Carvajal-Hausdorf, Daniel, McLaughlin, Joseph, Velcheti, Vamsidhar, Chen, Lieping, Sanmamed, Miguel, Herbst, Roy S, Rimm, David L
Publicado no J Immunother Cancer (2015)

Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer

Por Schalper, Kurt A., Brown, Jason, Carvajal-Hausdorf, Daniel, McLaughlin, Joseph, Velcheti, Vamsidhar, Syrigos, Konstantinos N., Herbst, Roy S., Rimm, David L.
Publicado no J Natl Cancer Inst (2015)

Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small cell lung cancer

Por Shibuya, Keiko, Komaki, Ritsuko, Shintani, Tomoaki, Itasaka, Satoshi, Ryan, Anderson, Jürgensmeier, Juliane M., Milas, Luka, Ang, Kian, Herbst, Roy S., O'Reilly, Michael S.
Publicado em 2007

Practice Patterns and Perceptions of Thoracic Oncology Providers on Tobacco Use and Cessation in Cancer Patients

Por Warren, Graham W., Marshall, James R., Cummings, K. Michael, Toll, Benjamin, Gritz, Ellen R., Hutson, Alan, Dibaj, Seyedeh, Herbst, Roy, Dresler, Carolyn
Publicado em 2013

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, place...

Por Herbst, Roy S, Ansari, Rafat, Bustin, Frederique, Flynn, Patrick, Hart, Lowell, Otterson, Gregory A, Vlahovic, Gordana, Soh, Chang-Heok, O’Connor, Paula, Hainsworth, John
Publicado em 2011

Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non–Small-Cell Lung Cancer: RTOG 0324

Por Blumenschein, George R., Paulus, Rebecca, Curran, Walter J., Robert, Francisco, Fossella, Frank, Werner-Wasik, Maria, Herbst, Roy S., Doescher, Philip O., Choy, Hak, Komaki, Ritsuko
Publicado em 2011

Tobacco Assessment in Actively Accruing National Cancer Institute Cooperative Group Program Clinical Trials

Por Peters, Erica N., Torres, Essie, Toll, Benjamin A., Cummings, K. Michael, Gritz, Ellen R., Hyland, Andrew, Herbst, Roy S., Marshall, James R., Warren, Graham W.
Publicado em 2012